Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects

Eur J Med Chem. 2022 Dec 15:244:114834. doi: 10.1016/j.ejmech.2022.114834. Epub 2022 Oct 5.

Abstract

In recent years, both metal-based complexes and selenium-containing compounds have been widely explored for their therapeutic properties due to their roles in biological processes and modulation of diverse molecular targets. However, despite their growing interest, there is no review to date that covers the potential use of the combination of these entities to design new therapeutic derivatives. This review highlights the latest achievements in this particular field, with a focus on compounds with anticancer and/or antimicrobial properties. With this aim, the formation of coordination compounds including several metals bearing selenium either with direct interaction with the metal center or as part of the organic ligand elsewhere is covered. Besides, coordination compounds with a Se(IV) center have been assessed. The biological properties of several selenium-containing organometallic complexes have also been discussed, including metallocenes, half-sandwich complexes, and compounds with N-heterocyclic carbenes, CO, and π-ligands, and other σ-bonded entities. The information compiled in this review may be helpful to design and develop novel, more potent, and safer metal-based compounds for the treatment of several pathologies.

Keywords: Coordination complex; Cytotoxicity; Organometallic compound; Selenium; Therapeutic activity.

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Antineoplastic Agents* / pharmacology
  • Biological Phenomena*
  • Coordination Complexes* / pharmacology
  • Coordination Complexes* / therapeutic use
  • Ligands
  • Metals
  • Organometallic Compounds* / pharmacology
  • Selenium* / pharmacology

Substances

  • Selenium
  • Antineoplastic Agents
  • Coordination Complexes
  • Ligands
  • Metals
  • Anti-Infective Agents
  • Organometallic Compounds